Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors

Detalles Bibliográficos
Autores principales: Ma, Chunlong, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923551/
https://www.ncbi.nlm.nih.gov/pubmed/33568498
http://dx.doi.org/10.1073/pnas.2024420118
_version_ 1783658925155942400
author Ma, Chunlong
Wang, Jun
author_facet Ma, Chunlong
Wang, Jun
author_sort Ma, Chunlong
collection PubMed
description
format Online
Article
Text
id pubmed-7923551
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-79235512021-03-10 Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors Ma, Chunlong Wang, Jun Proc Natl Acad Sci U S A Letter National Academy of Sciences 2021-02-23 2021-02-10 /pmc/articles/PMC7923551/ /pubmed/33568498 http://dx.doi.org/10.1073/pnas.2024420118 Text en Copyright © 2021 the Author(s). Published by PNAS. http://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Ma, Chunlong
Wang, Jun
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
title Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
title_full Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
title_fullStr Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
title_full_unstemmed Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
title_short Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
title_sort dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not sars-cov-2 main protease inhibitors
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923551/
https://www.ncbi.nlm.nih.gov/pubmed/33568498
http://dx.doi.org/10.1073/pnas.2024420118
work_keys_str_mv AT machunlong dipyridamolechloroquinemontelukastsodiumcandesartanoxytetracyclineandatazanavirarenotsarscov2mainproteaseinhibitors
AT wangjun dipyridamolechloroquinemontelukastsodiumcandesartanoxytetracyclineandatazanavirarenotsarscov2mainproteaseinhibitors

Ejemplares similares